Oxnard GR - Search Results

1

Traditional Diagnostics versus Disruptive Technology: The Role of the Pathologist in the Era of Liquid Biopsy.

Sholl LM, Oxnard GR, Paweletz CP. Sholl LM, et al. Among authors: oxnard gr. Cancer Res. 2020 Aug 15;80(16):3197-3199. doi: 10.1158/0008-5472.CAN-20-0134. Epub 2020 Jun 30. Cancer Res. 2020. PMID: 32606002 Free PMC article.

2

Non-small cell lung cancer in octogenarians: treatment practices and preferences.

Oxnard GR, Fidias P, Muzikansky A, Sequist LV. Oxnard GR, et al. J Thorac Oncol. 2007 Nov;2(11):1029-35. doi: 10.1097/JTO.0b013e318158d4a2. J Thorac Oncol. 2007. PMID: 17975495 Free article.

3

New strategies in overcoming acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer.

Oxnard GR, Arcila ME, Chmielecki J, Ladanyi M, Miller VA, Pao W. Oxnard GR, et al. Clin Cancer Res. 2011 Sep 1;17(17):5530-7. doi: 10.1158/1078-0432.CCR-10-2571. Epub 2011 Jul 20. Clin Cancer Res. 2011. PMID: 21775534 Free PMC article. Review.

4

Power in numbers: meta-analysis to identify inhibitor-sensitive tumor genotypes.

Oxnard GR, Jänne PA. Oxnard GR, et al. Clin Cancer Res. 2013 Apr 1;19(7):1634-6. doi: 10.1158/1078-0432.CCR-13-0169. Epub 2013 Feb 12. Clin Cancer Res. 2013. PMID: 23403632 Free PMC article.

5

Brunner AM, Costa DB, Heist RS, Garcia E, Lindeman NI, Sholl LM, Oxnard GR, Johnson BE, Hammerman PS. Brunner AM, et al. Among authors: oxnard gr. J Thorac Oncol. 2013 Nov;8(11):1434-7. doi: 10.1097/JTO.0b013e3182a47162. J Thorac Oncol. 2013. PMID: 24128713 Free PMC article. Clinical Trial.

6

Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA.

Oxnard GR, Paweletz CP, Kuang Y, Mach SL, O'Connell A, Messineo MM, Luke JJ, Butaney M, Kirschmeier P, Jackman DM, Jänne PA. Oxnard GR, et al. Clin Cancer Res. 2014 Mar 15;20(6):1698-1705. doi: 10.1158/1078-0432.CCR-13-2482. Epub 2014 Jan 15. Clin Cancer Res. 2014. PMID: 24429876 Free PMC article.

7

Management of acquired resistance to epidermal growth factor receptor kinase inhibitors in patients with advanced non-small cell lung cancer.

Sacher AG, Jänne PA, Oxnard GR. Sacher AG, et al. Among authors: oxnard gr. Cancer. 2014 Aug 1;120(15):2289-98. doi: 10.1002/cncr.28723. Epub 2014 Apr 17. Cancer. 2014. PMID: 24752335 Free PMC article. Review.

8

Realizing the potential of plasma genotyping in an age of genotype-directed therapies.

Luke JJ, Oxnard GR, Paweletz CP, Camidge DR, Heymach JV, Solit DB, Johnson BE; Cell Free DNA Working Group. Luke JJ, et al. Among authors: oxnard gr. J Natl Cancer Inst. 2014 Aug 8;106(8):dju214. doi: 10.1093/jnci/dju214. Print 2014 Aug. J Natl Cancer Inst. 2014. PMID: 25106647 Free PMC article.

9

Dacomitinib as first-line treatment in patients with clinically or molecularly selected advanced non-small-cell lung cancer: a multicentre, open-label, phase 2 trial.

Jänne PA, Ou SI, Kim DW, Oxnard GR, Martins R, Kris MG, Dunphy F, Nishio M, O'Connell J, Paweletz C, Taylor I, Zhang H, Goldberg Z, Mok T. Jänne PA, et al. Among authors: oxnard gr. Lancet Oncol. 2014 Dec;15(13):1433-1441. doi: 10.1016/S1470-2045(14)70461-9. Epub 2014 Nov 5. Lancet Oncol. 2014. PMID: 25456362 Clinical Trial.

10

Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in KRAS-Mutant Lung Adenocarcinoma.

Calles A, Sholl LM, Rodig SJ, Pelton AK, Hornick JL, Butaney M, Lydon C, Dahlberg SE, Oxnard GR, Jackman DM, Jänne PA. Calles A, et al. Among authors: oxnard gr. Clin Cancer Res. 2015 Jun 15;21(12):2851-60. doi: 10.1158/1078-0432.CCR-14-3112. Epub 2015 Mar 3. Clin Cancer Res. 2015. PMID: 25737507

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters